RNF31
Basic information
Region (hg38): 14:24146683-24160660
Links
Phenotypes
GenCC
Source:
- autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency 115 with autoinflammation | AR | Allergy/Immunology/Infectious | The condition involves susceptibility to infections, and and prophylactic measures, as well as early and aggressive treatment of infections with consideration of vaccine regimen, may be beneficial; For autoimmune sequelae, medical management (eg, with TNF antagonists), has been reported to be beneficial | Allergy/Immunology/Infectious | 26008899; 30936877 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF31 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 159 | 168 | ||||
missense | 306 | 315 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 10 | 22 | 32 | |||
non coding | 101 | 14 | 121 | |||
Total | 0 | 0 | 327 | 266 | 22 |
Variants in RNF31
This is a list of pathogenic ClinVar variants found in the RNF31 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-24147702-C-T | Uncertain significance (Jul 29, 2022) | |||
14-24147703-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
14-24147706-G-A | Uncertain significance (Dec 02, 2023) | |||
14-24147713-A-G | Likely benign (Sep 01, 2022) | |||
14-24147714-G-A | Uncertain significance (May 17, 2022) | |||
14-24147717-G-A | not specified | Uncertain significance (Aug 02, 2023) | ||
14-24147721-G-C | Uncertain significance (Mar 24, 2022) | |||
14-24147722-G-A | Likely benign (Oct 13, 2023) | |||
14-24147728-C-T | Likely benign (Aug 29, 2023) | |||
14-24147731-G-T | Likely benign (Nov 07, 2022) | |||
14-24147732-G-A | Uncertain significance (Jan 19, 2024) | |||
14-24147741-G-A | Uncertain significance (Apr 17, 2022) | |||
14-24147742-A-C | Uncertain significance (Apr 22, 2021) | |||
14-24147750-G-A | Uncertain significance (Dec 10, 2023) | |||
14-24147754-G-A | Uncertain significance (Nov 07, 2023) | |||
14-24147756-G-A | Uncertain significance (Sep 01, 2021) | |||
14-24147756-G-T | Uncertain significance (Dec 06, 2022) | |||
14-24147757-C-T | Uncertain significance (Mar 31, 2023) | |||
14-24147765-AG-A | Uncertain significance (Dec 06, 2023) | |||
14-24147769-A-G | Uncertain significance (Jan 04, 2024) | |||
14-24147772-C-G | Uncertain significance (Jun 14, 2023) | |||
14-24147775-G-C | Uncertain significance (Apr 20, 2023) | |||
14-24147780-G-A | Uncertain significance (Feb 18, 2023) | |||
14-24147782-G-A | Likely benign (Nov 23, 2022) | |||
14-24147787-C-G | Uncertain significance (Jul 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNF31 | protein_coding | protein_coding | ENST00000324103 | 21 | 13979 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000283 | 124805 | 0 | 13 | 124818 | 0.0000521 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.14 | 493 | 646 | 0.764 | 0.0000389 | 6883 |
Missense in Polyphen | 122 | 225.01 | 0.5422 | 2416 | ||
Synonymous | -0.970 | 273 | 253 | 1.08 | 0.0000137 | 2235 |
Loss of Function | 6.60 | 6 | 62.2 | 0.0965 | 0.00000353 | 618 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000584 | 0.0000584 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000111 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.0000710 | 0.0000706 |
Middle Eastern | 0.000111 | 0.000111 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase component of the LUBAC complex which conjugates linear ('Met-1'-linked) polyubiquitin chains to substrates and plays a key role in NF-kappa-B activation and regulation of inflammation (PubMed:17006537, PubMed:19136968, PubMed:20005846, PubMed:21455173, PubMed:21455180, PubMed:21455181, PubMed:22863777, PubMed:28189684). LUBAC conjugates linear polyubiquitin to IKBKG and RIPK1 and is involved in activation of the canonical NF-kappa-B and the JNK signaling pathways (PubMed:17006537, PubMed:19136968, PubMed:20005846, PubMed:21455173, PubMed:21455180, PubMed:21455181, PubMed:22863777, PubMed:28189684). Linear ubiquitination mediated by the LUBAC complex interferes with TNF-induced cell death and thereby prevents inflammation (PubMed:21455173, PubMed:28189684). LUBAC is recruited to the TNF-R1 signaling complex (TNF-RSC) following polyubiquitination of TNF-RSC components by BIRC2 and/or BIRC3 and to conjugate linear polyubiquitin to IKBKG and possibly other components contributing to the stability of the complex (PubMed:20005846, PubMed:27458237). Together with OTULIN, the LUBAC complex regulates the canonical Wnt signaling during angiogenesis (PubMed:23708998). Binds polyubiquitin of different linkage types (PubMed:23708998). {ECO:0000269|PubMed:17006537, ECO:0000269|PubMed:19136968, ECO:0000269|PubMed:20005846, ECO:0000269|PubMed:21455173, ECO:0000269|PubMed:21455180, ECO:0000269|PubMed:21455181, ECO:0000269|PubMed:22863777, ECO:0000269|PubMed:23708998, ECO:0000269|PubMed:27458237, ECO:0000269|PubMed:28189684}.;
- Pathway
- Necroptosis - Homo sapiens (human);NOD-like receptor signaling pathway - Homo sapiens (human);Regulation of toll-like receptor signaling pathway;Signal Transduction;TNFR1-induced NFkappaB signaling pathway;TNF signaling;Death Receptor Signalling;Regulation of TNFR1 signaling
(Consensus)
Recessive Scores
- pRec
- 0.387
Intolerance Scores
- loftool
- 0.427
- rvis_EVS
- -0.57
- rvis_percentile_EVS
- 19.01
Haploinsufficiency Scores
- pHI
- 0.168
- hipred
- Y
- hipred_score
- 0.542
- ghis
- 0.585
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.964
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf31
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- protein polyubiquitination;I-kappaB kinase/NF-kappaB signaling;regulation of tumor necrosis factor-mediated signaling pathway;CD40 signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB signaling;T cell receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;protein linear polyubiquitination;positive regulation of protein targeting to mitochondrion
- Cellular component
- cytosol;cytoplasmic side of plasma membrane;CD40 receptor complex;LUBAC complex
- Molecular function
- ubiquitin-protein transferase activity;protein binding;ubiquitin protein ligase binding;ubiquitin binding;metal ion binding